Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combined Deep Brain Stimulation in Parkinson's Disease

NCT: NCT05415774 · COMPLETED

NCT IDNCT05415774
StatusCOMPLETED
Start Date2022-09-09
Completion2023-05-10

Brief Summary

The study is a pilot study on Parkinson's disease patients to evaluate Combined deep brain stimulation of the substantia nigra pars reticulata and of the subthalamic nucleus for unresponsive freezing of gait.

Frequently Asked Questions

What is Combined Deep Brain Stimulation in Parkinson's Disease?

Combined Deep Brain Stimulation in Parkinson's Disease is a clinical trial registered under NCT05415774. Current status: COMPLETED.

What is the status of NCT05415774?

The current status of NCT05415774 (Combined Deep Brain Stimulation in Parkinson's Disease) is: COMPLETED.

When did Combined Deep Brain Stimulation in Parkinson's Disease start?

Combined Deep Brain Stimulation in Parkinson's Disease started on 2022-09-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.